tiprankstipranks
Advertisement
Advertisement
Transcenta Returns Two Lilly-Licensed Compounds in US$4 Million Deal, Retains Blosozumab Rights
PremiumCompany AnnouncementsTranscenta Returns Two Lilly-Licensed Compounds in US$4 Million Deal, Retains Blosozumab Rights
1M ago
Transcenta Grants New Share Awards and Options to Strengthen Staff Incentives
Premium
Company Announcements
Transcenta Grants New Share Awards and Options to Strengthen Staff Incentives
2M ago
Transcenta AGM Approvals Leave Board Short of Independence Targets
Premium
Company Announcements
Transcenta AGM Approvals Leave Board Short of Independence Targets
2M ago
Transcenta Gains Boost as Inhibrx’s Ozekibart Data and FDA Filing Strengthen Greater China Cancer Franchise
PremiumCompany AnnouncementsTranscenta Gains Boost as Inhibrx’s Ozekibart Data and FDA Filing Strengthen Greater China Cancer Franchise
3M ago
Transcenta Postpones AGM and Adjusts Share Register Closure Dates
Premium
Company Announcements
Transcenta Postpones AGM and Adjusts Share Register Closure Dates
3M ago
Transcenta Reports Strong Preclinical Results for LIV1-Targeting ADCs in Breast and Prostate Cancers
Premium
Company Announcements
Transcenta Reports Strong Preclinical Results for LIV1-Targeting ADCs in Breast and Prostate Cancers
4M ago
Transcenta Advances Dealmaking, Licensing and Financing to Resolve Audit Disclaimer and Bolster Liquidity
PremiumCompany AnnouncementsTranscenta Advances Dealmaking, Licensing and Financing to Resolve Audit Disclaimer and Bolster Liquidity
7M ago
Transcenta Grants 2 Million Incentive Shares to Key Employee Under Performance-Linked Scheme
Premium
Company Announcements
Transcenta Grants 2 Million Incentive Shares to Key Employee Under Performance-Linked Scheme
8M ago
Transcenta Licenses HiCB Biomanufacturing Platform to EirGenix in Strategic Collaboration
Premium
Company Announcements
Transcenta Licenses HiCB Biomanufacturing Platform to EirGenix in Strategic Collaboration
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100